Cytogen Stock Cash And Equivalents
217330 Stock | KRW 9,810 150.00 1.51% |
Cytogen fundamentals help investors to digest information that contributes to Cytogen's financial success or failures. It also enables traders to predict the movement of Cytogen Stock. The fundamental analysis module provides a way to measure Cytogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cytogen stock.
Cytogen |
Cytogen Company Cash And Equivalents Analysis
Cytogen's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Cytogen Cash And Equivalents | 30.29 B |
Most of Cytogen's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cytogen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Competition |
In accordance with the recently published financial statements, Cytogen has 30.29 B in Cash And Equivalents. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology & Medical Research industry. The cash and equivalents for all Republic of Korea stocks is significantly lower than that of the firm.
Cytogen Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cytogen's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cytogen could also be used in its relative valuation, which is a method of valuing Cytogen by comparing valuation metrics of similar companies.Cytogen is currently under evaluation in cash and equivalents category among related companies.
Cytogen Fundamentals
Return On Equity | -96.72 | |||
Return On Asset | -0.18 | |||
Operating Margin | (9.92) % | |||
Current Valuation | 324.23 B | |||
Shares Outstanding | 5.63 M | |||
Shares Owned By Insiders | 39.37 % | |||
Shares Owned By Institutions | 0.05 % | |||
Price To Sales | 487.61 X | |||
Revenue | 347.85 M | |||
Gross Profit | (129.63 M) | |||
EBITDA | (5.87 B) | |||
Net Income | (10.87 B) | |||
Cash And Equivalents | 30.29 B | |||
Total Debt | 20.9 B | |||
Debt To Equity | 0.33 % | |||
Current Ratio | 16.09 X | |||
Cash Flow From Operations | (5.23 B) | |||
Beta | 1.16 | |||
Market Capitalization | 95.89 B | |||
Total Asset | 55.53 B | |||
Z Score | 2.4 | |||
Net Asset | 55.53 B |
About Cytogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cytogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Cytogen information on this page should be used as a complementary analysis to other Cytogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Cytogen Stock analysis
When running Cytogen's price analysis, check to measure Cytogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytogen is operating at the current time. Most of Cytogen's value examination focuses on studying past and present price action to predict the probability of Cytogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytogen's price. Additionally, you may evaluate how the addition of Cytogen to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |